Updated clinical guideline for human papillomavirus vaccine: the Korean Society of Gynecologic Oncology guidelines

Hyun Woong Cho, Kyung Jin Min, Sang Hoon Kwon, Kidong Kim, Sunghoon Kim, Seok Ju Seong, Yong Jung Song, Keun Ho Lee, Shin Wha Lee, Jeong Won Lee, Woong Ju, Young Tae Kim, Jae Kwan Lee

Research output: Contribution to journalReview articlepeer-review

Abstract

Since the human papillomavirus (HPV) vaccine guidelines were developed by the Korean Society of Gynecologic Oncology (KSGO) in 2011, 2016, and 2019, several recent studies on the efficacy and safety of HPV vaccines in middle-aged women and men have been reported. Furthermore, there has been an ongoing debate regarding the efficacy of the HPV vaccine in women with prior HPV infection or who have undergone conization for cervical intraepithelial neoplasia (CIN). We searched and reviewed studies on the efficacy and safety of the HPV vaccine in middle-aged women and men and the efficacy of the HPV vaccine in patients infected with HPV and those who underwent conization for CIN. The KSGO updated their guidelines based on the results of the studies included in this review.

Original languageEnglish
Pages (from-to)e94
JournalJournal of Gynecologic Oncology
Volume32
Issue number6
DOIs
StatePublished - 1 Nov 2021

Keywords

  • Female
  • Male
  • Middle Aged
  • Papillomavirus Vaccines
  • Practice Guideline

Fingerprint

Dive into the research topics of 'Updated clinical guideline for human papillomavirus vaccine: the Korean Society of Gynecologic Oncology guidelines'. Together they form a unique fingerprint.

Cite this